RNU7-106P

Across TCGA pan-cancer cohorts, RNU7-106P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU7-106P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RNU7-106P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-106P expression acts as an unfavorable survival marker.

PAAD, LUSC, and LIHC are the cancer types where RNU7-106P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.068	0.484	<.001	72	view →
LUSC	OS	Tertile	III,IV	0.001	0.684	<.001	72	view →
LIHC	OS	Tertile	III,IV	0.270	0.732	.021	36	view →
BLCA	OS	Tertile	IV	0.132	0.599	.004	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU7-106P–PAAD (DFS)

Open the PAAD breakdown →